Skip to Content

Biomedicines, Volume 4, Issue 3

2016 September - 11 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (11)

  • Feature Paper
  • Review
  • Open Access
11 Citations
5,492 Views
14 Pages

Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts

  • Jing Li Huang,
  • Christopher J. LaRocca and
  • Masato Yamamoto

Oncolytic adenoviruses (OAds) are increasingly recognized as vectors for immunotherapy in the treatment of various solid tumors. The myriads of advantages of using adenovirus include targeted specificity upon infection and selective replication, whic...

(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer)
  • Feature Paper
  • Article
  • Open Access
4 Citations
6,040 Views
13 Pages

An Abraded Surface of Doxorubicin-Loaded Surfactant-Containing Drug Delivery Systems Effectively Reduces the Survival of Carcinoma Cells

  • Christian Schmidt,
  • Fabiano Yokaichiya,
  • Nurdan Doğangüzel,
  • Margareth K. K. Dias Franco and ,
  • Leide P. Cavalcanti,
  • Mark A. Brown,
  • Melissa I. Alkschbirs,
  • Daniele R. De Araujo,
  • Mont Kumpugdee-Vollrath and
  • Joachim Storsberg
  • + 5 authors+ 0 author

An effective antitumor remedy is yet to be developed. All previous approaches for a targeted delivery of anticancer medicine have relied on trial and error. The goal of this study was to use structural insights gained from the study of delivery syste...

(This article belongs to the Section Immunology and Immunotherapy)
  • Feature Paper
  • Review
  • Open Access
11 Citations
7,517 Views
19 Pages

The past decade has seen considerable excitement in the use of biological therapies in treating neoplastic disease. In particular, cancer immunotherapy and oncolytic virotherapy have emerged as two frontrunners in this regard with the first FDA appro...

(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer)
  • Review
  • Open Access
33 Citations
8,875 Views
20 Pages

Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials

  • Minnie Au,
  • Theophilus I. Emeto,
  • Jacinta Power,
  • Venkat N. Vangaveti and
  • Hock C. Lai

Pancreatic cancer is an aggressive disease with a five year survival rate of less than 5%, which is associated with late presentation. In recent years, research into nanomedicine and the use of nanoparticles as therapeutic agents for cancers has incr...

(This article belongs to the Section Immunology and Immunotherapy)
  • Feature Paper
  • Review
  • Open Access
31 Citations
8,854 Views
13 Pages

Oncolytic viruses (OVs) are being extensively studied for their potential roles in the development of cancer therapy regimens. In addition to their direct lytic effects, OVs can initiate and drive systemic antitumor immunity indirectly via release of...

(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer)
  • Feature Paper
  • Review
  • Open Access
66 Citations
10,188 Views
20 Pages

From Benchtop to Bedside: A Review of Oncolytic Virotherapy

  • Audrey H. Choi,
  • Michael P. O’Leary,
  • Yuman Fong and
  • Nanhai G. Chen

Oncolytic viruses (OVs) demonstrate the ability to replicate selectively in cancer cells, resulting in antitumor effects by a variety of mechanisms, including direct cell lysis and indirect cell death through immune-mediate host responses. Although t...

(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer)
  • Article
  • Open Access
11 Citations
6,310 Views
10 Pages

In Vitro Anti-Oxidant and Anti-Microbial Potentiality Investigation of Different Fractions of Caryota urens Leaves

  • Shofiul Azam,
  • Md. Kayes Mahmud,
  • Md. Hamza Naquib,
  • Saad Mosharraf Hossain and ,
  • Mohammad Nazmul Alam,
  • Md. Josim Uddin,
  • Irfan Sajid,
  • Muhammad Sazzad Hossain,
  • Md. Salimul Karim and
  • Md. Ali Hasan
  • + 5 authors+ 0 author

Background: Caryota urens is a member of the Arecaceae family and a common plant in the Southeast Asian region. This plant has been reported as an anti-microbial agent in recent years. Thus, we aimed to find out the MIC (minimum inhibitory concentrat...

  • Article
  • Open Access
16 Citations
7,376 Views
34 Pages

Design, Synthesis and Biochemical Evaluation of Novel Selective Estrogen Receptor Ligand Conjugates Incorporating an Endoxifen-Combretastatin Hybrid Scaffold

  • Niall O. Keely,
  • Miriam Carr,
  • Bassem Yassin,
  • Gloria Ana and ,
  • David G. Lloyd,
  • Daniela Zisterer and
  • Mary J. Meegan
  • + 2 authors+ 0 author

Nuclear-receptors are often overexpressed in tumours and can thereby be used as targets when designing novel selective chemotherapeutic agents. To date, many conjugates incorporating an estrogen receptor (ER) ligand have been synthesised in order to...

(This article belongs to the Special Issue Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy)
  • Feature Paper
  • Review
  • Open Access
78 Citations
9,511 Views
14 Pages

This review provides an overview of 50 years of basic and clinical research on an oncolytic avian virus, Newcastle Disease Virus (NDV), which has particular anti-neoplastic and immune stimulatory properties. Of special interest is the fact that this...

(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer)
  • Review
  • Open Access
96 Citations
17,742 Views
17 Pages

Antibody–Drug Conjugates for Cancer Therapy

  • Adam C. Parslow,
  • Sagun Parakh,
  • Fook-Thean Lee,
  • Hui K. Gan and
  • Andrew M. Scott

Antibody–drug conjugates (ADCs) take advantage of the specificity of a monoclonal antibody to deliver a linked cytotoxic agent directly into a tumour cell. The development of these compounds provides exciting opportunities for improvements in patient...

(This article belongs to the Special Issue Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy)
  • Feature Paper
  • Review
  • Open Access
42 Citations
9,095 Views
9 Pages

Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?

  • Nicholas L. Denton,
  • Chun-Yu Chen,
  • Thomas R. Scott and
  • Timothy P. Cripe

Cancer therapy remains a challenge due to toxicity limitations of chemotherapy and radiation therapy. Oncolytic viruses that selectively replicate and destroy cancer cells are of increasing interest. In addition to direct cell lysis, these vectors st...

(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer)
XFacebookLinkedIn
Biomedicines - ISSN 2227-9059